Correlation Between Adverum Biotechnologies and BioLineRx
Can any of the company-specific risk be diversified away by investing in both Adverum Biotechnologies and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adverum Biotechnologies and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adverum Biotechnologies and BioLineRx, you can compare the effects of market volatilities on Adverum Biotechnologies and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adverum Biotechnologies with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adverum Biotechnologies and BioLineRx.
Diversification Opportunities for Adverum Biotechnologies and BioLineRx
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Adverum and BioLineRx is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Adverum Biotechnologies and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Adverum Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adverum Biotechnologies are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Adverum Biotechnologies i.e., Adverum Biotechnologies and BioLineRx go up and down completely randomly.
Pair Corralation between Adverum Biotechnologies and BioLineRx
Given the investment horizon of 90 days Adverum Biotechnologies is expected to generate 0.7 times more return on investment than BioLineRx. However, Adverum Biotechnologies is 1.42 times less risky than BioLineRx. It trades about 0.11 of its potential returns per unit of risk. BioLineRx is currently generating about 0.05 per unit of risk. If you would invest 227.00 in Adverum Biotechnologies on May 21, 2025 and sell it today you would earn a total of 66.00 from holding Adverum Biotechnologies or generate 29.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Adverum Biotechnologies vs. BioLineRx
Performance |
Timeline |
Adverum Biotechnologies |
BioLineRx |
Adverum Biotechnologies and BioLineRx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adverum Biotechnologies and BioLineRx
The main advantage of trading using opposite Adverum Biotechnologies and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adverum Biotechnologies position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.Adverum Biotechnologies vs. Regenxbio | Adverum Biotechnologies vs. Anebulo Pharmaceuticals | Adverum Biotechnologies vs. Invivyd | Adverum Biotechnologies vs. Abeona Therapeutics |
BioLineRx vs. Protalix Biotherapeutics | BioLineRx vs. Corvus Pharmaceuticals | BioLineRx vs. Aldeyra | BioLineRx vs. Can Fite Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |